References
- Newman A., Clutterbuck R. D., Powles R. L., Millar J. L. Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin. Leukemia 1994; 8: 2023–2029
- Newman A., Clutterbuck R. D., DeLord C., Powles R. L., Catovsky D., Millar J. L. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: A potential purging agent for autologous bone marrow transplantation. J. Investig. Med. 1995; 43: 269–274
- Chapuis B., Summersgill B. M., Cocks P., Howard P., Lawler S. D., Alexander P., Powles R. Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements. Cryobiology 1977; 14: 637–648
- Pike B. L., Robinson W. A. Human bone marrow colony growth in agar-gel. J. Cell Physiol. 1970; 76: 77–84
- Zar J. H. Biostatistical Analysis, 2nd ed. Prentice-Hall, Englewood Cliffs, NJ 1984; 176
- Cohen L. H., Van Vliet A., Roodenburg L., Jansen L. M. C., Griffioen M. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Biochemical Pharmacology 1993; 45: 2203–2208
- Pentikainen P. J., Saraheimo M., Schwartz J. I., Amin R. D., Schwartz M. S., Brunner-Ferber F., Rogers J. D. Comparative Pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J. Clin. Pharmacol. 1992; 32: 136–140